We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Diagnostic Blood Test Determines Irritable Bowel Syndrome

By LabMedica International staff writers
Posted on 21 Nov 2013
A blood test could easily determine whether a patient is suffering from Irritable Bowel Syndrome (IBS), eliminating the need for extensive and expensive dialogistic testing in order to rule out more serious conditions like Inflammatory Bowel Disease (IBD). More...


Vinculin is a cell migration and adherence protein found predominantly on nerves and epithelium and a series of studies suggests that acute gastroenteritis causes antibodies to be formed to vinculin and is associated with IBS development.

Scientists at the Cedars Sinai Medical Center (Los Angeles, CA, USA) evaluated 165 IBS, 30 IBD and 26 healthy control subjects and demographics were similar between groups. The IBS subjects were aged between 18 and 65 and were all positive according to the Rome criteria. Subjects with IBD were recruited from an expert tertiary care medical center.

Overall, IBS had a significantly greater optical density in the enzyme-linked immunoassay (ELISA) for anti-vinculin antibodies compared to IBD and healthy subjects. The results from Cedars Sinai Medical Center were compared to those at Beth Israel Deaconess Medical Center (Boston, MA, USA) for IBS recruitment, and the findings from both centers were similarly abnormal. Interestingly, subjects with a history of acute gastroenteritis, even higher levels of antibodies were seen.

Mark Pimentel, MD, the lead author of this multicenter study, said, “Anti-vinculin antibodies are elevated in IBS compared to non-IBS. This is the first diagnostic test for IBS based on serum and a pathophysiologic mechanism of IBS through acute gastroenteritis precipitating molecular mimicry and autoimmunity. This is a major breakthrough as the first test to potentially distinguish IBS from IBD and reduce the need for unnecessary testing in these conditions. Moreover, this test is based on a potential pathophysiologic mechanism of IBS development.”

In the USA, it is estimated that 10%–15% of the adult population suffers from IBS symptoms, yet only 5%–7% of adults have been diagnosed with the disease. IBS is the most common disease diagnosed by gastroenterologists and one of the most common disorders seen by primary care physicians. The study was presented at 78th Annual Scientific Meeting of the American College of Gastroenterology, held October 11-16, 2013, in San Diego (CA, USA).

Related Links:

Cedars Sinai Medical Center
Beth Israel Deaconess Medical Center 



New
Gold Member
Automatic CLIA Analyzer
Shine i9000
Portable Electronic Pipette
Mini 96
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Blood Glucose Test Strip
AutoSense Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: A schematic illustrating the coagulation cascade in vitro (Photo courtesy of Harris, N., 2024)

ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners

Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read more

Microbiology

view channel
Image: EBP and EBP plus have received FDA 510(k) clearance and CE-IVDR Certification for use on the BD COR system (Photo courtesy of BD)

High-Throughput Enteric Panels Detect Multiple GI Bacterial Infections from Single Stool Swab Sample

Gastrointestinal (GI) infections are among the most common causes of illness worldwide, leading to over 1.7 million deaths annually and placing a heavy burden on healthcare systems. Conventional diagnostic... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.